secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001104659-25-098360
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dogwood Therapeutics posts Q4 2025 update presentation; no specific data in excerpt
--------------------------------------------------------------------------------

- Presentation filed as Exhibit 99.1 highlights first-in-class therapies for cancer neuropathy.
- No financial results, clinical data, or guidance changes included in the provided excerpt.
- Filed as Regulation FD disclosure; presentation may be used with investors and analysts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000110465925098360/0001104659-25-098360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000110465925098360/dwtx-20251009x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer